| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/27/2013 | EP2560655A1 Substituted pyrimidines |
| 02/27/2013 | EP2143444A9 Compositions for inhibition of angiogenesis |
| 02/27/2013 | CN102947291A Prodrug of triazolone compound |
| 02/27/2013 | CN102946893A Composition containing colored bean extract |
| 02/27/2013 | CN102942638A Preparation method for dextran with weight average molecular weight of 3000-6000Da |
| 02/27/2013 | CN102940886A Biological barrier penetrating agent and preparation method thereof |
| 02/27/2013 | CN102940841A Traditional Chinese medicine composition for treating ascites syndrome |
| 02/27/2013 | CN102940826A Traditional Chinese medicinal liquor for treatment of diabetic retinopathy |
| 02/27/2013 | CN102940804A Drug for performing disinfection, stopping bleeding and healing sore and preparation method |
| 02/27/2013 | CN102940797A Traditional Chinese medicine composition for treating stranguria and preparation method thereof |
| 02/27/2013 | CN102940793A Traditional Chinese medicine composition for treating purpura |
| 02/27/2013 | CN102940734A Traditional Chinese medicine for treating purpura |
| 02/27/2013 | CN102940729A Pure natural drug for treating thalassemia |
| 02/27/2013 | CN102940702A Medicine composition for treating cardia-cerebrovascular diseases |
| 02/27/2013 | CN102940676A Medicine composition for treating cardia-cerebrovascular diseases |
| 02/27/2013 | CN102940669A Medicine composition for treating cardia-cerebrovascular diseases |
| 02/27/2013 | CN102940667A Total flemingia philippinensis flavonoid extract and extracting method and medicinal application thereof |
| 02/27/2013 | CN102940632A Application of FK506-A compound in preparation of immunosuppressant |
| 02/27/2013 | CN102940625A Applications of Eryngiolide A in platelet increase drugs |
| 02/27/2013 | CN102940622A 腹膜透析液 Peritoneal dialysate |
| 02/27/2013 | CN102552591B Application of pain-relief anti-inflammation ointment to curing cerebral edema of contusion and laceration of brain |
| 02/27/2013 | CN102382747B Chinese herbal health care wine and manufacturing method thereof |
| 02/27/2013 | CN102228680B Thymosin phospholipids/bile salt compound micelle and preparation method and preparation thereof |
| 02/27/2013 | CN102204967B Preparation method for safflower care-free tablet |
| 02/27/2013 | CN102100736B Method for simultaneously extracting water-soluble and lipid-soluble effective components in traditional Chinese medicine salvia miltiorrhiza bunge |
| 02/27/2013 | CN101888846B Stable bicarbonate ion-containing drug solution |
| 02/27/2013 | CN101757631B Composition of biocompatible microparticles of alginic acid for the controlled release of active ingredients by intravenous administration |
| 02/27/2013 | CN101010102B Composition comprising non-oxidizable fatty acid analogoues and plant and/or fish oils |
| 02/26/2013 | CA2542035C Process for producing antithrombin iii composition |
| 02/26/2013 | CA2389644C A novel polypeptide hormone phosphatonin |
| 02/21/2013 | WO2013025918A2 Methods useful in the prevention of hypoxic injury |
| 02/21/2013 | WO2013025467A2 Methods of treating hematological proliferative disorders by targeting epha3 expressed on aberrant vasculature in bone marrow |
| 02/21/2013 | WO2013023511A1 Triazolopyrimidine derivative and preparation method and use thereof |
| 02/21/2013 | WO2013003449A3 Methods of treatment with glp-1 receptor agonists |
| 02/21/2013 | WO2012172427A3 Peptide compounds for inhibition of platelet aggregation |
| 02/21/2013 | WO2012141536A3 Composition for regenerating connective tissue, and method for regenerating connective tissue |
| 02/21/2013 | US20130046020 Eicosapentaenoic acid concentrate |
| 02/21/2013 | US20130046004 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/21/2013 | US20130045997 Pirfenidone therapy and inducers of of cytochrome p450 |
| 02/21/2013 | US20130045991 Neuroprotective modulation of nmda receptor subtype activities |
| 02/21/2013 | US20130045983 Hsp90 inhibitors for therapeutic treatment |
| 02/21/2013 | US20130045277 Biocompatible device |
| 02/21/2013 | US20130045251 Pharmaceutical composition for improving solubility of prasugrel and its preparation method |
| 02/21/2013 | US20130045245 Apixaban formulations |
| 02/21/2013 | US20130045213 Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesity |
| 02/21/2013 | US20130045198 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof |
| 02/21/2013 | US20130045192 Reagents and methods for detecting pnh type ii white blood cells and their identification as risk factors for thrombotic disorders |
| 02/21/2013 | US20130045186 Method of Detecting and/or Identifying Adeno-Associated Virus (AAV) Sequences and Isolating Novel Sequences Identified Thereby |
| 02/21/2013 | US20130045183 Boswellia oil, its fractions and compositions for enhancing brain function |
| 02/20/2013 | EP2559442A1 Method for regulating microrna content in organisms and uses thereof |
| 02/20/2013 | EP2558465A1 Tricyclic pyridyl-vinyl pyrroles as par1 inhibitors |
| 02/20/2013 | CN102939108A Conjugated blood coagulation factor viii |
| 02/20/2013 | CN102939087A Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof |
| 02/20/2013 | CN102939077A Nanoemulsion composition containing vitamin k |
| 02/20/2013 | CN102936555A Semen pharbitidis health-care wine capable of preventing and treating oedema |
| 02/20/2013 | CN102936288A Erythropoietin mimetic peptide fusion protein and mutant |
| 02/20/2013 | CN102935231A Treatments using citrulline |
| 02/20/2013 | CN102935182A Neonatal jaundice treatment decoction |
| 02/20/2013 | CN102935173A Medicament for treating agranulocytosis in combination with mycotic infection of hemopathic patients |
| 02/20/2013 | CN102935153A Qi reinforcing qianzheng pills for cerebral thrombosis disease treatment |
| 02/20/2013 | CN102935147A Chinese patent medicinal gastric floating tablet for treating gastrorrhagia and method for preparing same |
| 02/20/2013 | CN102935125A Externally applied Chinese herbal composition with facial redness removing effect, preparation and method for preparing externally applied Chinese herbal composition with facial redness removing effect |
| 02/20/2013 | CN102935115A Drug for treating myelodysplastic syndrome |
| 02/20/2013 | CN102935102A Method for simultaneously producing honeysuckle flower distillate and various active substances |
| 02/20/2013 | CN102935085A Hemostatic drug formulation for cock castration operation |
| 02/20/2013 | CN102250261B New method for producing iron dextran |
| 02/20/2013 | CN101849675B Dietary supplements containing natural ingredients |
| 02/19/2013 | US8377950 Crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt |
| 02/19/2013 | US8377887 Methods of reducing hypoxic stress in a mammal by administering soluble P-selectin |
| 02/19/2013 | CA2448382C Use of hepcidin as a regulator of iron homeostasis |
| 02/14/2013 | WO2013022982A2 Pegylated tyrosyl-trna synthetase polypeptides |
| 02/14/2013 | WO2013022814A1 Cyclic p1 linkers as factor xia inhibitors |
| 02/14/2013 | WO2013022406A1 Angiopoietin-like 4 and its use in modulating cell leakiness |
| 02/14/2013 | WO2013022059A1 Pharmaceutical composition containing diamine derivative |
| 02/14/2013 | WO2013022012A1 Carrier for adsorption and method for producing same |
| 02/14/2013 | WO2012135064A3 Attenuated strains of plasmodium |
| 02/14/2013 | US20130042334 Capping-Prone RNA Polymerase Enzymes and Their Applications |
| 02/14/2013 | US20130041137 von Willebrand Factor (vWF) - Cleaving Protease |
| 02/14/2013 | US20130041007 Selective Androgen Receptor Modulators |
| 02/14/2013 | US20130040997 Novel pyridine carboxylic acid based compound used as a p2x1 and p2x3 receptor antagonist, a production method for the same and a composition comprising the same |
| 02/14/2013 | US20130040981 Pyridylvinylpyrazoloquinolines as PAR1 inhibitors |
| 02/14/2013 | US20130040970 Co-Crystals Of A Triazolo [4,5-D] Pyrimide Platelet Aggregation Inhibitor |
| 02/14/2013 | US20130040950 Multisubstituted aromatic compounds as inhibitors of thrombin |
| 02/14/2013 | US20130040946 Substituted imidazopyrimidines and triazolopyrimidines |
| 02/14/2013 | US20130040943 Tricyclic pyridyl-vinyl pyrroles as par1 inhibitors |
| 02/14/2013 | US20130040916 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses |
| 02/14/2013 | US20130040890 Lyophilization methods, compositions, and kits |
| 02/14/2013 | US20130040889 Factor VIII Fusion Protein |
| 02/14/2013 | US20130040888 Factor VIII Molecules With Reduced VWF Binding |
| 02/14/2013 | US20130040887 Inhibiting Collagen-Induced Platelet Aggregation and Activation with Peptide Variants |
| 02/14/2013 | US20130040886 Peptides and Methods for Inhibiting G alpha Protein Signaling |
| 02/14/2013 | US20130040885 Collagen pad |
| 02/14/2013 | US20130039981 Quick Dissolving, Long Acting Zinc Therapeutic Formulations |
| 02/14/2013 | US20130039907 Methods of treating hematological proliferative disorders by targeting epha3 expressed on aberrant vasculature in bone marrow |
| 02/14/2013 | US20130039902 Non-neurotoxic plasminogen activating factors for treating of stroke |
| 02/14/2013 | US20130039898 Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof |
| 02/14/2013 | US20130039895 Mir-150 for the treatment of blood disorders |
| 02/14/2013 | US20130039892 Adherent stromal cells derived from plancentas of multiple donors and uses thereof |
| 02/14/2013 | US20130039850 Heterologous antibodies which bind human cd4 |
| 02/14/2013 | US20130039848 Fluorescent silica-based nanoparticles |